US20150066070A1 - Side branch balloon - Google Patents

Side branch balloon Download PDF

Info

Publication number
US20150066070A1
US20150066070A1 US14/546,696 US201414546696A US2015066070A1 US 20150066070 A1 US20150066070 A1 US 20150066070A1 US 201414546696 A US201414546696 A US 201414546696A US 2015066070 A1 US2015066070 A1 US 2015066070A1
Authority
US
United States
Prior art keywords
balloon
catheter
stent
distal
proximal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/546,696
Inventor
Nadia P. Matov
Jayson De Los Santos
Guillermo Piva
Tanhum Feld
Eitan Konstantino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trireme Medical LLC
Original Assignee
Trireme Medical LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trireme Medical LLC filed Critical Trireme Medical LLC
Priority to US14/546,696 priority Critical patent/US20150066070A1/en
Publication of US20150066070A1 publication Critical patent/US20150066070A1/en
Assigned to TRIREME MEDICAL, INC. reassignment TRIREME MEDICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FELD, TANHUM, KONSTANTINO, EITAN, DE LOS SANTOS, JAYSON, MATOV, NADIA P., PIVA, GUILLERMO
Assigned to TriReme Medical, LLC reassignment TriReme Medical, LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: TRIREME MEDICAL, INC.
Assigned to TELEFLEX LIFE SCIENCES UNLIMITED COMPANY reassignment TELEFLEX LIFE SCIENCES UNLIMITED COMPANY LICENSE (SEE DOCUMENT FOR DETAILS). Assignors: QT VASCULAR LTD., QUATTRO VASCULAR PTE. LTD., TRIREME MEDICAL (SINGAPORE) PTE. LTD., TriReme Medical, LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/104Balloon catheters used for angioplasty
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2002/061Blood vessels provided with means for allowing access to secondary lumens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • A61F2002/9583Means for holding the stent on the balloon, e.g. using protrusions, adhesives or an outer sleeve
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M2025/0059Catheters; Hollow probes characterised by structural features having means for preventing the catheter, sheath or lumens from collapsing due to outer forces, e.g. compressing forces, or caused by twisting or kinking
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1045Balloon catheters with special features or adapted for special applications for treating bifurcations, e.g. balloons in y-configuration, separate balloons or special features of the catheter for treating bifurcations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1068Balloon catheters with special features or adapted for special applications having means for varying the length or diameter of the deployed balloon, this variations could be caused by excess pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1079Balloon catheters with special features or adapted for special applications having radio-opaque markers in the region of the balloon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1081Balloon catheters with special features or adapted for special applications having sheaths or the like for covering the balloon but not forming a permanent part of the balloon, e.g. retractable, dissolvable or tearable sheaths
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1093Balloon catheters with special features or adapted for special applications having particular tip characteristics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/0105Steering means as part of the catheter or advancing means; Markers for positioning
    • A61M25/0108Steering means as part of the catheter or advancing means; Markers for positioning using radio-opaque or ultrasound markers

Definitions

  • the present invention relates to medical methods and devices, more specifically to medical dilatation balloon catheters.
  • Balloon catheters often need to cross through luminal obstructions, such as stent struts, occlusions, and tight turns.
  • luminal obstructions such as stent struts, occlusions, and tight turns.
  • One particular obstructions is encountered when treating stenosis present at an arterial bifurcation. Treatment of a bifurcation site is challenging since they are Y-shaped and require a different approach from a simple lesion treated with a regular cylindrical stent.
  • the usual practice is to place a cylindrical stent in the main vessel across the bifurcation ostium which typically results in partially blocking (“jailing”) the side branch ostium with stent struts.
  • the struts may be opened by advancing an angioplasty balloon over a guide wire through the stent struts so that a distal portion of the balloon is inside the side branch. If all goes well, the balloon may then be inflated to open struts and clear the ostium.
  • a second stent may be delivered into the side branch and placed with its proximal end as close as possible to the main vessel stent in an attempt to place the stents in a Y-pattern.
  • the outer surface of a conventional folded balloon can also catch on stent struts.
  • Angioplasty balloons are folded in order to assume a small diameter for delivery. These folds or pleats often catch on stent struts if advanced through a cell. The tendency of the balloon to catch is worsened when the catheter turns from the main vessel into the side branch, causing the balloon to bend and partially unwrapping the pleats. In some cases the balloon tip may also bend and twist, further hindering the progress of the catheter.
  • dilation balloons are typically at least 8 mm in length or are provided with external blades or cages to prevent slippage.
  • a balloon catheter addressing some of the issues noted above will be desirable.
  • Enhanced torqueability is a key element of such balloon catheter.
  • Catheters having beveled or chamfered distal tips are described in U.S. Pat. Nos. 3,884,242; 5,967,988; 6,010,449; 6,206,852; 6,966,902; and 7,306,575 and in U.S. Publ. Application No. 2009/024212. Balloon and other catheters having torsionally reinforced distal ends are described in U.S. Pat. Nos. 4,994,032; 5,827,231; 5,997,487; 6,994,687; and 7,022,106. Catheters having “short” balloons and having balloons with mid-line markers are described in U.S. Pat. Nos.
  • This invention provides balloon catheters having improved “pushability” (column strength and asymmetric tip design) and torqueability (torsional stiffness), particularly through the distal balloon section.
  • the balloon catheters of the present invention have an improved ability to cross obstacles and obstructions, such as stent struts and tight turns with improved physician control, improved ostium expansion, and reduced injury to the vasculature using the benefits of asymmetric tip design coupled with torque transmission properties.
  • Such balloon catheters are useful for a variety of cardiology procedures, including angioplasty, drug delivery, stent deployment, and the like, and have particular advantages when employed vascular bifurcations.
  • the balloon catheter tip is formed in asymmetric manner (e.g. beveled, asymmetrically tapered, differential stiffness across the circumference of the tip) to allow improved crossability overcoming obstacles, such as stent struts, by rotating and realigning the asymmetric tip relative to the obstruction.
  • beveled it is meant that the distal tip of the catheter has a at least one planar or non-planar surface at its leading end, where at least a portion of the surface is at a non-perpendicular angle relative to the axis of the catheter body typically from 30° to 70°.
  • the leading end is formed by a planar “cut” across the distal tip.
  • the beveled end could have one or more non-planar surfaces or facets, at least some of which are inclined relative to the catheter body axis.
  • the balloon catheter shaft is designed to transmit torque applied by an operator so that the distal tip can be rotated. Combination of the beveled tip and improved torsional stiffness (torque transmission) improves the crossing properties more than either feature alone.
  • the balloon catheter comprises a “torque bridge” to allow torque delivery through the balloon region of the catheter body.
  • the torque bridge can be in a form of cylindrical polymer sleeve disposed over or attached to at least a portion of the balloon and covering the balloon taper and all or part of the balloon working length.
  • Such sleeves can cause the balloon to progressively inflate from the proximal end toward the distal end, which can be advantageous in opening stent cells.
  • Such torque bridge can take other forms, as well, such as metal reinforcement for the proximal balloon segment or welding of the inner member to the balloon proximal leg to improve structural stability during rotation.
  • the torque bridge of the present invention increases rotational accuracy and stent deployment precision by minimizing uncontrolled rotation resulting from “unwinding” of the catheter or portions thereof during balloon inflation and stent deployment.
  • the torque bridge of the present invention enhances the ability of the stent to rotate since the system does not absorb torque. Torque absorption in the prior art is sometimes caused by windup of catheter components such as balloon folds, distal shaft and, for catheters having two guidewires side branch wire lumen wrap on the main vessel wire lumen and others.
  • the torque bridge is used to enhance rotation and/or self rotation of bifurcation stents and stent delivery systems by minimizing torque storage and by minimizing wire wrap which is a well known limitation of bifurcation delivery systems.
  • the torque bridge improves torque transmission and crossability by covering the balloon folds and applying elastic pressure to enhance column strength in this area of the balloon.
  • the structural integrity of the balloon which otherwise would have a limited ability to resist forces in circumferential direction, increases significantly and torque can be delivered through the balloon segment.
  • the balloon or inflatable shell
  • the sleeve is designed to compress the folds while still allowing the balloon to inflate and deflate during the deployment of the balloon and optionally to carry stents or other components or devices during the deployment.
  • the sleeve will also reinforce the catheter shaft to improve axial force transmission and allow push forces to be transmitted all the way to the balloon to assist in overcoming obstacles.
  • Such improved column strength and pushability is beneficial for the delivery of all types of stents including bifurcation stents which requires rotational alignment.
  • the torque bridge is used for a stent delivery system of bifurcation stent with side branch apparatus or hole or crown that needs to be aligned to the side branch.
  • the balloon catheter comprises a thin wall cylindrical polymer sleeve attached to the balloon's distal end and covers the balloon's distal taper and at least part of the balloon's working length, thus covering the balloon folds creating a smooth passage through difficult obstacles further improving crossability and handling.
  • the sleeve can be made of elastic polymer such as pebax or polyurethane or nylon or alike and can be coated with lubricious coating to improve crossing. Furthermore, this polymer sleeve controls balloon inflation by creating an axial expansion movement in addition to the conventional radial expansion. This is particularly beneficial in treating side branch ostiums.
  • the balloon catheter comprises a thin wall polymer sleeve attached to the balloon's proximal end and covers the balloon's proximal taper and at least part of the balloon's working length.
  • This “torque bridge” allows improved torque delivery all the way to the balloon by elastically constraining the proximal balloon pleats and eliminating the “candy wrap’ effect thus enhancing the control of the operator.
  • This novel design of the “torque bridge” enabling rotation of the beveled tip offers enhanced crossing abilities and overcoming obstacles.
  • the balloon catheter comprises of a small (“football shaped”) balloon typically with a working length of 3 to 6 mm sometimes with total lengths of 10 mm, 15 mm, or longer.
  • the balloon will have distal and proximal tapers having lengths of 2.5 mm to 4 mm on either side of the working length in the middle.
  • This balloon can be used to dilate a bifurcation ostium without slipping due to axial reinforcement of the torqueable catheter shaft.
  • a middle or mid-line radiopaque marker will usually be provided on the balloon or shaft underlying the balloon to permit alignment of the balloon with the ostium and/or the stent wall prior to balloon inflation.
  • the combination of beveled tip and torque bridge is used for long balloons for peripheral applications to improve crossing through diffused and calcified lesions by allowing the operator to torque the catheter and navigate the asymmetric tip through the lesion(s).
  • a balloon catheter with improved crossing characteristics comprises a catheter body having a distal end, a proximal end, and an inflatable lumen near the distal end.
  • a distal tip of the catheter body is asymmetrically beveled relative to an axis of the catheter body and at least a distal portion of the catheter body is torsionally reinforced to improve the ability to rotate the beveled tip by torquing a proximal end of the catheter body when the catheter is present in the vasculature.
  • the beveled tip may be a simple planar bevel at an angle relative to the axis of the catheter in the range from 25° to 75°, usually at an angle in the range from 30° to 60°.
  • the catheter tip may be tapered one or more times between the maximum diameter region of the catheter body and the distal tip which is beveled.
  • the distal tip may be beveled along two, three, four or more surfaces so that the tip resembles a diamond or trocar tip.
  • the beveled tip without torque reinforcement is not functional in crossing lesions and may even be inferior to regular tip since its structural integrity is lower than regular tip (less materials and the distal end of the tip) and it may deform. Coupling this tip with torque reinforcement allows new way of crossing obstacles that was never used with balloon catheters due to the inability of the inflatable shell to deliver torque.
  • Torsional reinforcement of the catheter may include a variety of structures.
  • a distal region of the catheter typically at least over or within the balloon, may comprise a reinforcement sleeve.
  • an elastic reinforcement sleeve may cover a distal region of the balloon, a proximal region of the balloon, or in some cases the entire balloon.
  • the elastic sleeve will not only provide additional column strength, thus increasing the torsional rigidity of the distal region of the catheter, it will also smooth the exterior surface of the catheter presented to the blood vessel and stent or other obstructions as the catheter is being advanced. In this way, the folds and discontinuous surface of the balloon may be covered and protected against engaging the stent struts or other obstructions.
  • the stent body within the balloon may be reinforced by conventional structures, such as braids, coils, axial reinforcement elements, or the like.
  • the sleeves may be non-elastic or non-distensible but frangible so that they split, fracture or rupture as the balloon is inflated.
  • the balloon will have a particularly short length, typically from 3 mm to 6 mm, so that it may be inflated within a stent wall (typically within a single stent cell) to open the stent cell, while only a short portion of the balloon extends into the side branch and a similarly short portion of the balloon remains within the lumen of the stent in the main vessel.
  • the short balloons will have a radiopaque marker at or near their midsections so that the balloon can be aligned with the stent wall and/or the side vessel ostium prior to inflation.
  • the catheters described above may be used for advancing the catheter tip past obstructions present within a patient's vasculature.
  • the distal end of the catheter may be observed fluoroscopically as it is being advanced through the vasculature. If the stent encounters an obstruction, such as a stent strut, when attempting to enter a side branch vessel from a main branch vessel, the user may torque the stent from the proximal end, causing the beveled distal end to rotate and change its orientation relative to the obstruction. By continuing to rotate the stent and gently advance the stent, an orientation which allows the stent to atraumatically pass the obstruction will usually be found, and the catheter can be advanced forward. In some instances, after the balloon on the catheter is disposed within the cell of the stent, the balloon may be expanded to expand the stent cell.
  • a balloon catheter having improved stent crossing characteristics comprises a catheter body having a distal end, a proximal end, and an inflatable balloon near the distal end.
  • the balloon will have a short length, typically in the range from 3 mm to 6 mm, and a radiopaque marker at its middle.
  • the balloon is preferably non-distensible and has a diameter in the range from 1 mm to 5 mm when fully inflated. This balloon may be used in methods for opening a cell in a stent deployed in a main branch vessel of a patient's vasculature.
  • the method comprises advancing the short balloon into a cell adjacent to a side branch vessel so that the radiopaque marker is aligned with the cell or the ostium and a distal half of the balloon is advanced into the branch vessel and a proximal half of the balloon remains within a central lumen of the stent. After properly positioning the balloon, the balloon is inflated to open the stent cell.
  • FIGS. 1A to 1D show catheter tips approaching a stent strut.
  • FIG. 1A shows a prior art catheter.
  • FIGS. 1B to 1C show a catheter according to the present invention, comprising a beveled or skived catheter tip, approaching the stent strut.
  • FIG. 2 shows a catheter of the present invention with a polymer sleeve that is attached over a distal portion of the balloon.
  • FIGS. 3A to 3B show an axially progressive expansion of the balloon catheter of FIG. 2 .
  • FIGS. 4A to 4B show a catheter of the present invention having a polymer sleeve attached over a proximal portion of the balloon in accordance with the present invention.
  • FIGS. 5A and 5B show expansion of a short balloon with a stent cell at a vascular bifurcation in accordance with the present invention.
  • the present invention provides catheters and methods for their use with the improved ability to cross obstructions as they are advanced through a patient's vasculature, particularly the coronary vasculature.
  • Obstructions which can be overcome by the catheters and methods of the present invention include tight turns, eccentric occlusions, and most particularly, stent struts present at a bifurcation.
  • one or more struts which form part of a main vessel stent placed at a vessel bifurcation will often be located across the ostium leading into the side or branch vessel.
  • the catheters and methods of the present invention are able to advance past such jailing stent struts in at least most cases.
  • a first design element includes a beveled distal tip at a leading end of the catheter.
  • the bevel will generally include at least one planar surface or face disposed at an angle in the range from 30° to 60° relative to a central longitudinal axis of the catheter, usually in the range from 40° to 50° relative to the axis.
  • the distal tip may include two or more of such inclined or beveled surfaces.
  • a second design element of the catheter comprises torsional reinforcement over at least a distal portion of the catheter, typically over at least a distal or proximal portion of the balloon of the catheter.
  • a third design element of the catheter is the use of a short balloon, typically in the range from 3 mm to 6 mm, which is particularly useful for expanding a cell or other aperture and its stent which is aligned with the ostium of a bifurcation.
  • a short balloon typically in the range from 3 mm to 6 mm, which is particularly useful for expanding a cell or other aperture and its stent which is aligned with the ostium of a bifurcation.
  • Such short balloons will preferably have a middle or a mid-line marker, typically a radiopaque marker on the catheter shaft, to facilitate positioning the short catheter at the ostium or within the struts of a stent adjacent the ostium.
  • a prior art balloon catheter 10 would typically have a distal end or tip 12 with a blunt leading edge 14 which is oriented at 90° relative to the longitudinal axis 15 of the catheter.
  • a distally converging taper 16 typically a conical section, but because of the limitations of catheter fabrication described above, the blunt leading edge 14 would still present a square as shoulder the catheter is advanced over the guidewire GW.
  • the shoulder would create a substantial risk of catching or engaging a stent strut SS or other luminal obstruction, thus compromising the ability to advance the catheter through the vasculature or other body lumen, and particularly through side branch ostia covered by stents.
  • a catheter 20 constructed in accordance with the principles of the present invention will have a distal tip 22 having a beveled leading edge 24 .
  • the beveled leading edge is typically formed at the distal end of a tapered or conical section 26 located distal to the main body 28 and balloon 42 (shown schematically) of the catheter.
  • the beveled leading edge 24 of catheter 20 can still engage or catch stent struts SS as the catheter is advanced through the wall of a stent disposed at a side branch ostium, particularly if the distalmost tip 30 is rotationally aligned engage the stent strut, as shown in FIG. 1B .
  • the catheter 20 of the present invention allows the user to rotate the catheter body about the guidewire GW so that another portion of the leading edge 24 , such as the trailing surface 32 of the leading edge engages the stent strut SS, as shown in FIG. 1C .
  • the trailing edge which trails away from the direction of advancement, allows the stent to easily move past the stent strut SS and into the branch vessel.
  • the beveled leading edge 24 will preferably consist of a single surface having generally planar geometry (other than the aperture or opening for passing the guidewire) as illustrated in FIGS. 1B and 1C
  • a catheter 20 having a plurality of beveled or inclined surfaces 34 , 36 , and 38 , as illustrated in FIG. 1D .
  • the distal tip which then resembles a trocar cutting element having a plurality of facets, is even less likely to engage and interfere with the stent strut SS, although it is still possible to rotate the catheter should any difficulty be encountered in moving the catheter past the stent strut.
  • the balloon tip can be beveled at various angles, preferable lower than 65 degrees and optimally at about 45-30 degrees. Bevel angle is measured between the beveled surface and the longitudinal axis of the catheter. It can be done on one side or both sides ( FIG. 1D ) to prevent bias of the tip. If the angle is too steep (e.g., lower than 30 degree) the unbeveled area is too long and can bend out when interfering with obstacles thereby creating risk of tip deformation, dislodgment and patient safety. If the angle is not steep enough (e.g. less than 75 degree) the advantage of the bevel is insignificant as the front tip cross section will interfere with the obstacle similar to conventional tip design.
  • the catheter 20 will preferably have torsional reinforcement over at least a distal region of the catheter body.
  • an exemplary form of torsional reinforcement comprises a sleeve 40 formed over at least a distal portion of expandable balloon 42 .
  • the sleeve 40 which is typically elastic and has a smooth exterior surface, optionally having a lubricious film or coating disposed over the surface, will significantly reduce the risk that the folds of the balloon may interfere with or be captured by a stent strut or other obstruction as the catheter is advanced.
  • FIGS. 3A and 3B Inflation of the balloon 42 is illustrated in FIGS. 3A and 3B , where the balloon first expands in a proximal portion not covered by the sleeve 40 .
  • the inflation “front” reaches the sleeve, which then inflates from its proximal end, as shown in FIG. 3B , toward the distal end.
  • the elastic sleeve 40 helps close and deflate the balloon.
  • the sleeve 40 help with introducing the balloon catheter, it can also facilitate with removing the balloon catheter.
  • the sleeve 40 need not be elastic, and in other embodiments could be inelastic or non-distensible. In such cases, the inelastic sleeve will typically have a frangible line or portion which permits it to split, rupture, or fracture upon balloon inflation. In order to facilitate withdrawal, the split sections could be adhered to the balloon surface so that they close with deflation of the balloon. In other instances, it may be desirable to cover the entire balloon with an elastic or inelastic sleeve, and in all cases, the sleeve will add to the column strength and torsional stiffness of the distal portion of the balloon section of the catheter. Such increased strength and stiffness combined to enhance the resistance to bending and to torsional buildup. Together, increased resistance to bending and torsional buildup will increase the efficiency of delivering the axial forces from a proximal end of the catheter to the distal end to overcome the obstruction of the stent strut or other materials.
  • the ability to progressively inflate the balloon from a proximal end toward a distal end can have particular advantage, when opening a stent or otherwise treating a side branch ostium.
  • it is common to dilate the ostium after stent deployment by positioning a distal end of the balloon in the side branch and a proximal end of the balloon in the main vessel.
  • the balloon is inflated to dilate the ostium and position the stent struts outwardly toward the side branch in order to cover and “scaffold” the ostium.
  • this procedure often pushes struts which are located distally to the balloon back into the main vessel rather than into the side branch.
  • the present invention also provides for placing a constraining sleeve over a proximal portion of the balloon.
  • a sleeve 50 which may be elastic or inelastic as described above, covers a proximal taper of the balloon 52 of catheter 48 in order to cover the pleats of the folded balloon and inhibit the balloon from catching on the struts of a stent, particularly as the catheter is withdrawn through the stent.
  • the sleeve 50 is preferably formed from an elastic material which can recover to close a balloon and the balloon is deflated. Thus, when the procedure is over, the proximal region of the balloon will be constrained and a smooth surface presented as the catheter is withdrawn.
  • proximal balloon 50 also enhances both torsional stiffness and column strength, a feature which is particularly useful when the balloon is adapted to deliver stents.
  • catheter 48 of FIGS. 4A and 4B will be combined with a beveled distal tip 54 and optionally a braided proximal shaft portion 56 in order to further enhance torsional stiffness and column strength.
  • the braided shaft section 56 may be attached to a proximal shaft 58 which may be a hypotube, conventional polymeric balloon catheter shaft, or the like.
  • a balloon catheter 70 carries a short balloon 72 having a length less than 12 mm, usually less than 8 mm, and typically in the range from 3 mm to 6 mm.
  • the balloon catheter 70 usually carries a radiopaque marker 74 at the approximate middle or mid-line of the balloon (middle of the axial dimension of the inflated balloon).
  • the marker 74 is carried on the shaft within the balloon and will be visible under fluoroscopy to allow the middle of the balloon, i.e. the marker, to be positioned at the ostium or stent wall before inflation.
  • a distal half of the balloon is positioned largely within the side branch vessel lumen SBL, while a proximal half of the balloon remains largely in the main branch vessel lumen MBL.
  • the ostium is usually larger than the side branch vessel diameter, typically by about 0.5 mm, long balloons will generally enter the side branch increasing the risk of overdilation when the user is attempting to dilate stenotic material located at the ostium (which is a very typical occurrence).
  • Use of the short balloons of the present invention minimizes the risk of overinflation of the side branch vessel.
  • a further advantage of the short balloon is that it does not extend far into either the main branch vessel lumen MBL or side branch vessel lumen SBL.
  • Longer balloons which extend proximally back into the main branch will tend to straighten as they are inflated. As the proximal end of a long balloon can be anchored within the main branch vessel, such straightening will then deflect the distal end of the balloon downward, thus preferentially opening struts on one side of the ostium and potentially causing an uneven dilatation.

Abstract

An improved balloon catheter structure includes a beveled distal tip, a reinforced distal portion, and an elastic or split sleeve over at least a portion of the balloon. The balloon may have a short length and a marker at its midline. The catheters are particularly useful for crossing through stent walls at vessel bifurcations.

Description

    CROSS-REFERENCE
  • This application is a continuation of U.S. patent application Ser. No. 12/795,911 (Attorney Docket No. 32164-710.201, previously 022246-001510US), filed on Jun. 8, 2010, which claimed the benefit of Provisional Application No. 61/185,124 (Attorney Docket No. 022246-001500US), filed on Jun. 8, 2009, the full disclosure of which is incorporated herein by reference.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • The present invention relates to medical methods and devices, more specifically to medical dilatation balloon catheters.
  • Balloon catheters often need to cross through luminal obstructions, such as stent struts, occlusions, and tight turns. One particular obstructions is encountered when treating stenosis present at an arterial bifurcation. Treatment of a bifurcation site is challenging since they are Y-shaped and require a different approach from a simple lesion treated with a regular cylindrical stent. When treating stenosis at bifurcation, it is common practice to use a conventional cylindrical stent and, after implantation, manipulate the stent's geometry using a balloon catheter to accommodate the bifurcated anatomy.
  • The usual practice is to place a cylindrical stent in the main vessel across the bifurcation ostium which typically results in partially blocking (“jailing”) the side branch ostium with stent struts. The struts may be opened by advancing an angioplasty balloon over a guide wire through the stent struts so that a distal portion of the balloon is inside the side branch. If all goes well, the balloon may then be inflated to open struts and clear the ostium. Optionally, if the side branch is diseased or not expanded widely enough, a second stent may be delivered into the side branch and placed with its proximal end as close as possible to the main vessel stent in an attempt to place the stents in a Y-pattern.
  • Crossing into the side branch with an angioplasty balloon, however, can be difficult. The catheter tip and/or balloon that is threaded on a guide wire is often caught by the stent struts and the catheter cannot be advanced. This phenomenon is enhanced because the guide wire always has bias and is leaning on the nearest stent strut. The distal tips of balloon catheters are not designed to pass obstructions such as stent struts. The tips are usually soft and atraumatic to provide smooth passage without scratching the artery walls during delivery. Soft tips are prone to deformation and are more difficult to push past struts and other obstructions. The clearance between the catheter tip and the guidewire is usually large, again exacerbating the difficulty of pushing the tip past obstructions.
  • Conventional balloon catheter shafts are not designed to transmit torque, particularly over their distal segments near the balloon. Often, the distal-most 25-30 cm of the shaft is made from a soft, low profile and thin wall polymer material which is very ineffective for torque transmission. In addition, the majority of the torque is lost in the inflatable shell or the balloon which is made of a thin polymer shell (typically nylon or pebax) and is floating over the distal end of the catheter. Attempts to rotate the catheter will result in twisting of the polymer shaft followed by unfolding of the balloon pleats (referred to as the “candy wrapper effect”) and increasing profile and risk of damaging the catheter without meaningful torque transmission to the tip. Therefore, when the catheter tip is caught in a stent strut or other obstruction, the operator can only move the catheter back and forth, poking the strut and hoping that the catheter will somehow be able to overcome and cross it. This process is unpredictable and uncontrolled, both in terms of success and of the possible damage caused. Inability to cross is documented in the literature and is a common issue in bifurcations and other occlusions.
  • The outer surface of a conventional folded balloon can also catch on stent struts. Angioplasty balloons are folded in order to assume a small diameter for delivery. These folds or pleats often catch on stent struts if advanced through a cell. The tendency of the balloon to catch is worsened when the catheter turns from the main vessel into the side branch, causing the balloon to bend and partially unwrapping the pleats. In some cases the balloon tip may also bend and twist, further hindering the progress of the catheter.
  • When treating bifurcations, it is common practice to dilate the side-branch ostium. Clinical studies have shown a high correlation between post procedure (acute) ostium size and long term patency of the side branch vessel. However, large ostium dilations are not easily achieved. Measurements of human bifurcation anatomy show that the ostium size is significantly bigger than the side branch diameter. For side branch vessels between 2.5 to 3.0 mm diameters, the ostium is usually about 0.5 mm bigger. When using a regular sized balloon, the difference in diameter between the side-branch ostium and the side-branch can result in either over expansion in the side branch causing injury to the side branch or under-deployment in the ostium. Often a “kissing balloon” technique is performed where two balloons are deployed in the main vessel. Two balloons, however, can cause anatomical deformation and excessive pressure in the main vessel. Furthermore, struts and other stent components are not advantageously placed. While short balloons could alleviate these problems, a short balloon would have a tendency to slip and lose its longitudinal position in the vessel. Therefore, dilation balloons are typically at least 8 mm in length or are provided with external blades or cages to prevent slippage.
  • A balloon catheter addressing some of the issues noted above will be desirable. In particular, it would be desirable to provide a balloon catheter with improved crossability achieved through adding another degree of control to the operator and a new dimension to the procedure by adding asymmetric tip design such as skived, beveled or similar configuration that can be re-oriented by rotation when facing an obstacle. Enhanced torqueability is a key element of such balloon catheter.
  • 2. Description of the Background Art
  • Catheters having beveled or chamfered distal tips are described in U.S. Pat. Nos. 3,884,242; 5,967,988; 6,010,449; 6,206,852; 6,966,902; and 7,306,575 and in U.S. Publ. Application No. 2009/024212. Balloon and other catheters having torsionally reinforced distal ends are described in U.S. Pat. Nos. 4,994,032; 5,827,231; 5,997,487; 6,994,687; and 7,022,106. Catheters having “short” balloons and having balloons with mid-line markers are described in U.S. Pat. Nos. 5,295,962; 5,324,261; 5,669,932; 6,692,483; and 6,884,258; and in U.S. Publ. Application Nos. 2004/186560; 2006/100694; 2008/045896; and 2009/048655. Catheters having sleeves over at least a portion of an angioplasty or other balloon are described in U.S. Pat. Nos. 5,628,755; 6,068,634; 6,679,900; 6,695,863; 6,699,273; and 6,830,575; and U.S. Publ. Application Nos. 2005/203463 and 2009/112159.
  • SUMMARY OF THE INVENTION
  • This invention provides balloon catheters having improved “pushability” (column strength and asymmetric tip design) and torqueability (torsional stiffness), particularly through the distal balloon section. The balloon catheters of the present invention have an improved ability to cross obstacles and obstructions, such as stent struts and tight turns with improved physician control, improved ostium expansion, and reduced injury to the vasculature using the benefits of asymmetric tip design coupled with torque transmission properties. Such balloon catheters are useful for a variety of cardiology procedures, including angioplasty, drug delivery, stent deployment, and the like, and have particular advantages when employed vascular bifurcations.
  • In one embodiment, the balloon catheter tip is formed in asymmetric manner (e.g. beveled, asymmetrically tapered, differential stiffness across the circumference of the tip) to allow improved crossability overcoming obstacles, such as stent struts, by rotating and realigning the asymmetric tip relative to the obstruction. By “beveled”, it is meant that the distal tip of the catheter has a at least one planar or non-planar surface at its leading end, where at least a portion of the surface is at a non-perpendicular angle relative to the axis of the catheter body typically from 30° to 70°. Usually, the leading end is formed by a planar “cut” across the distal tip. In other cases there may be two or more planar cuts to form facets, each of which is at an angle relative to the axis of the catheter body. In other instances, the beveled end could have one or more non-planar surfaces or facets, at least some of which are inclined relative to the catheter body axis.
  • In one embodiment, the balloon catheter shaft is designed to transmit torque applied by an operator so that the distal tip can be rotated. Combination of the beveled tip and improved torsional stiffness (torque transmission) improves the crossing properties more than either feature alone.
  • In one embodiment, the balloon catheter comprises a “torque bridge” to allow torque delivery through the balloon region of the catheter body. The torque bridge can be in a form of cylindrical polymer sleeve disposed over or attached to at least a portion of the balloon and covering the balloon taper and all or part of the balloon working length. Such sleeves can cause the balloon to progressively inflate from the proximal end toward the distal end, which can be advantageous in opening stent cells. Such torque bridge can take other forms, as well, such as metal reinforcement for the proximal balloon segment or welding of the inner member to the balloon proximal leg to improve structural stability during rotation.
  • The torque bridge of the present invention increases rotational accuracy and stent deployment precision by minimizing uncontrolled rotation resulting from “unwinding” of the catheter or portions thereof during balloon inflation and stent deployment. The torque bridge of the present invention enhances the ability of the stent to rotate since the system does not absorb torque. Torque absorption in the prior art is sometimes caused by windup of catheter components such as balloon folds, distal shaft and, for catheters having two guidewires side branch wire lumen wrap on the main vessel wire lumen and others. In one embodiment of the present invention, the torque bridge is used to enhance rotation and/or self rotation of bifurcation stents and stent delivery systems by minimizing torque storage and by minimizing wire wrap which is a well known limitation of bifurcation delivery systems.
  • The torque bridge improves torque transmission and crossability by covering the balloon folds and applying elastic pressure to enhance column strength in this area of the balloon. The structural integrity of the balloon, which otherwise would have a limited ability to resist forces in circumferential direction, increases significantly and torque can be delivered through the balloon segment. Without the sleeve, the balloon (or inflatable shell) is virtually floating on the catheter attached to the distal shaft in one end and to the inner member at the distal tip. Therefore, torque cannot be efficiently delivered through this segment of the catheter. The sleeve is designed to compress the folds while still allowing the balloon to inflate and deflate during the deployment of the balloon and optionally to carry stents or other components or devices during the deployment. The sleeve will also reinforce the catheter shaft to improve axial force transmission and allow push forces to be transmitted all the way to the balloon to assist in overcoming obstacles. Such improved column strength and pushability is beneficial for the delivery of all types of stents including bifurcation stents which requires rotational alignment. In another embodiment the torque bridge is used for a stent delivery system of bifurcation stent with side branch apparatus or hole or crown that needs to be aligned to the side branch.
  • In one embodiment, the balloon catheter comprises a thin wall cylindrical polymer sleeve attached to the balloon's distal end and covers the balloon's distal taper and at least part of the balloon's working length, thus covering the balloon folds creating a smooth passage through difficult obstacles further improving crossability and handling. The sleeve can be made of elastic polymer such as pebax or polyurethane or nylon or alike and can be coated with lubricious coating to improve crossing. Furthermore, this polymer sleeve controls balloon inflation by creating an axial expansion movement in addition to the conventional radial expansion. This is particularly beneficial in treating side branch ostiums.
  • In one embodiment the balloon catheter comprises a thin wall polymer sleeve attached to the balloon's proximal end and covers the balloon's proximal taper and at least part of the balloon's working length. This “torque bridge” allows improved torque delivery all the way to the balloon by elastically constraining the proximal balloon pleats and eliminating the “candy wrap’ effect thus enhancing the control of the operator. This novel design of the “torque bridge” enabling rotation of the beveled tip offers enhanced crossing abilities and overcoming obstacles.
  • In one embodiment of this invention, the balloon catheter comprises of a small (“football shaped”) balloon typically with a working length of 3 to 6 mm sometimes with total lengths of 10 mm, 15 mm, or longer. In specific examples, the balloon will have distal and proximal tapers having lengths of 2.5 mm to 4 mm on either side of the working length in the middle. This balloon can be used to dilate a bifurcation ostium without slipping due to axial reinforcement of the torqueable catheter shaft. A middle or mid-line radiopaque marker will usually be provided on the balloon or shaft underlying the balloon to permit alignment of the balloon with the ostium and/or the stent wall prior to balloon inflation.
  • In another embodiment the combination of beveled tip and torque bridge is used for long balloons for peripheral applications to improve crossing through diffused and calcified lesions by allowing the operator to torque the catheter and navigate the asymmetric tip through the lesion(s).
  • Thus, in a first aspect of the present invention, a balloon catheter with improved crossing characteristics comprises a catheter body having a distal end, a proximal end, and an inflatable lumen near the distal end. A distal tip of the catheter body is asymmetrically beveled relative to an axis of the catheter body and at least a distal portion of the catheter body is torsionally reinforced to improve the ability to rotate the beveled tip by torquing a proximal end of the catheter body when the catheter is present in the vasculature. The beveled tip may be a simple planar bevel at an angle relative to the axis of the catheter in the range from 25° to 75°, usually at an angle in the range from 30° to 60°. Optionally, the catheter tip may be tapered one or more times between the maximum diameter region of the catheter body and the distal tip which is beveled. The distal tip may be beveled along two, three, four or more surfaces so that the tip resembles a diamond or trocar tip. The beveled tip without torque reinforcement is not functional in crossing lesions and may even be inferior to regular tip since its structural integrity is lower than regular tip (less materials and the distal end of the tip) and it may deform. Coupling this tip with torque reinforcement allows new way of crossing obstacles that was never used with balloon catheters due to the inability of the inflatable shell to deliver torque.
  • Torsional reinforcement of the catheter may include a variety of structures. In a first exemplary structure, a distal region of the catheter, typically at least over or within the balloon, may comprise a reinforcement sleeve. For example, an elastic reinforcement sleeve may cover a distal region of the balloon, a proximal region of the balloon, or in some cases the entire balloon. The elastic sleeve will not only provide additional column strength, thus increasing the torsional rigidity of the distal region of the catheter, it will also smooth the exterior surface of the catheter presented to the blood vessel and stent or other obstructions as the catheter is being advanced. In this way, the folds and discontinuous surface of the balloon may be covered and protected against engaging the stent struts or other obstructions. Alternatively or additionally, the stent body within the balloon may be reinforced by conventional structures, such as braids, coils, axial reinforcement elements, or the like. As an alternative to the elastic sleeves, the sleeves may be non-elastic or non-distensible but frangible so that they split, fracture or rupture as the balloon is inflated. In some instances, the balloon will have a particularly short length, typically from 3 mm to 6 mm, so that it may be inflated within a stent wall (typically within a single stent cell) to open the stent cell, while only a short portion of the balloon extends into the side branch and a similarly short portion of the balloon remains within the lumen of the stent in the main vessel. Such short stents have greatly improved the ability to dilate the ostium at the bifurcation. Preferably, the short balloons will have a radiopaque marker at or near their midsections so that the balloon can be aligned with the stent wall and/or the side vessel ostium prior to inflation.
  • In another aspect of the present invention, the catheters described above may be used for advancing the catheter tip past obstructions present within a patient's vasculature. The distal end of the catheter may be observed fluoroscopically as it is being advanced through the vasculature. If the stent encounters an obstruction, such as a stent strut, when attempting to enter a side branch vessel from a main branch vessel, the user may torque the stent from the proximal end, causing the beveled distal end to rotate and change its orientation relative to the obstruction. By continuing to rotate the stent and gently advance the stent, an orientation which allows the stent to atraumatically pass the obstruction will usually be found, and the catheter can be advanced forward. In some instances, after the balloon on the catheter is disposed within the cell of the stent, the balloon may be expanded to expand the stent cell.
  • In yet another aspect of the present invention, a balloon catheter having improved stent crossing characteristics comprises a catheter body having a distal end, a proximal end, and an inflatable balloon near the distal end. The balloon will have a short length, typically in the range from 3 mm to 6 mm, and a radiopaque marker at its middle. The balloon is preferably non-distensible and has a diameter in the range from 1 mm to 5 mm when fully inflated. This balloon may be used in methods for opening a cell in a stent deployed in a main branch vessel of a patient's vasculature. The method comprises advancing the short balloon into a cell adjacent to a side branch vessel so that the radiopaque marker is aligned with the cell or the ostium and a distal half of the balloon is advanced into the branch vessel and a proximal half of the balloon remains within a central lumen of the stent. After properly positioning the balloon, the balloon is inflated to open the stent cell.
  • INCORPORATION BY REFERENCE
  • All publications, patents, and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
  • FIGS. 1A to 1D show catheter tips approaching a stent strut. FIG. 1A shows a prior art catheter. FIGS. 1B to 1C show a catheter according to the present invention, comprising a beveled or skived catheter tip, approaching the stent strut.
  • FIG. 2 shows a catheter of the present invention with a polymer sleeve that is attached over a distal portion of the balloon.
  • FIGS. 3A to 3B show an axially progressive expansion of the balloon catheter of FIG. 2.
  • FIGS. 4A to 4B show a catheter of the present invention having a polymer sleeve attached over a proximal portion of the balloon in accordance with the present invention.
  • FIGS. 5A and 5B show expansion of a short balloon with a stent cell at a vascular bifurcation in accordance with the present invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The present invention provides catheters and methods for their use with the improved ability to cross obstructions as they are advanced through a patient's vasculature, particularly the coronary vasculature. Obstructions which can be overcome by the catheters and methods of the present invention include tight turns, eccentric occlusions, and most particularly, stent struts present at a bifurcation. As discussed earlier, one or more struts which form part of a main vessel stent placed at a vessel bifurcation will often be located across the ostium leading into the side or branch vessel. The catheters and methods of the present invention are able to advance past such jailing stent struts in at least most cases.
  • The catheters and methods of the present invention may comprise and utilize various design elements which facilitate the catheter passage through obstructions. A first design element includes a beveled distal tip at a leading end of the catheter. The bevel will generally include at least one planar surface or face disposed at an angle in the range from 30° to 60° relative to a central longitudinal axis of the catheter, usually in the range from 40° to 50° relative to the axis. Optionally, the distal tip may include two or more of such inclined or beveled surfaces. A second design element of the catheter comprises torsional reinforcement over at least a distal portion of the catheter, typically over at least a distal or proximal portion of the balloon of the catheter. A third design element of the catheter is the use of a short balloon, typically in the range from 3 mm to 6 mm, which is particularly useful for expanding a cell or other aperture and its stent which is aligned with the ostium of a bifurcation. Such short balloons will preferably have a middle or a mid-line marker, typically a radiopaque marker on the catheter shaft, to facilitate positioning the short catheter at the ostium or within the struts of a stent adjacent the ostium.
  • Referring to FIG. 1A, a prior art balloon catheter 10 would typically have a distal end or tip 12 with a blunt leading edge 14 which is oriented at 90° relative to the longitudinal axis 15 of the catheter. In order to facilitate advancement, such catheters would often have a distally converging taper 16, typically a conical section, but because of the limitations of catheter fabrication described above, the blunt leading edge 14 would still present a square as shoulder the catheter is advanced over the guidewire GW. The shoulder would create a substantial risk of catching or engaging a stent strut SS or other luminal obstruction, thus compromising the ability to advance the catheter through the vasculature or other body lumen, and particularly through side branch ostia covered by stents.
  • Referring now to FIGS. 1B and 1C, a catheter 20 constructed in accordance with the principles of the present invention will have a distal tip 22 having a beveled leading edge 24. The beveled leading edge is typically formed at the distal end of a tapered or conical section 26 located distal to the main body 28 and balloon 42 (shown schematically) of the catheter.
  • The beveled leading edge 24 of catheter 20 can still engage or catch stent struts SS as the catheter is advanced through the wall of a stent disposed at a side branch ostium, particularly if the distalmost tip 30 is rotationally aligned engage the stent strut, as shown in FIG. 1B. In contrast to the prior art catheter 10, however, the catheter 20 of the present invention allows the user to rotate the catheter body about the guidewire GW so that another portion of the leading edge 24, such as the trailing surface 32 of the leading edge engages the stent strut SS, as shown in FIG. 1C. The trailing edge, which trails away from the direction of advancement, allows the stent to easily move past the stent strut SS and into the branch vessel.
  • Although the beveled leading edge 24 will preferably consist of a single surface having generally planar geometry (other than the aperture or opening for passing the guidewire) as illustrated in FIGS. 1B and 1C, it is also possible to provide a catheter 20 having a plurality of beveled or inclined surfaces 34, 36, and 38, as illustrated in FIG. 1D. The distal tip, which then resembles a trocar cutting element having a plurality of facets, is even less likely to engage and interfere with the stent strut SS, although it is still possible to rotate the catheter should any difficulty be encountered in moving the catheter past the stent strut.
  • The balloon tip can be beveled at various angles, preferable lower than 65 degrees and optimally at about 45-30 degrees. Bevel angle is measured between the beveled surface and the longitudinal axis of the catheter. It can be done on one side or both sides (FIG. 1D) to prevent bias of the tip. If the angle is too steep (e.g., lower than 30 degree) the unbeveled area is too long and can bend out when interfering with obstacles thereby creating risk of tip deformation, dislodgment and patient safety. If the angle is not steep enough (e.g. less than 75 degree) the advantage of the bevel is insignificant as the front tip cross section will interfere with the obstacle similar to conventional tip design.
  • The catheter 20 will preferably have torsional reinforcement over at least a distal region of the catheter body. As shown in FIG. 2, an exemplary form of torsional reinforcement comprises a sleeve 40 formed over at least a distal portion of expandable balloon 42. The sleeve 40, which is typically elastic and has a smooth exterior surface, optionally having a lubricious film or coating disposed over the surface, will significantly reduce the risk that the folds of the balloon may interfere with or be captured by a stent strut or other obstruction as the catheter is advanced.
  • Inflation of the balloon 42 is illustrated in FIGS. 3A and 3B, where the balloon first expands in a proximal portion not covered by the sleeve 40. As the proximal portion fully inflates, the inflation “front” reaches the sleeve, which then inflates from its proximal end, as shown in FIG. 3B, toward the distal end. Upon deflation, the elastic sleeve 40 helps close and deflate the balloon. Thus, not only does the sleeve 40 help with introducing the balloon catheter, it can also facilitate with removing the balloon catheter.
  • The sleeve 40 need not be elastic, and in other embodiments could be inelastic or non-distensible. In such cases, the inelastic sleeve will typically have a frangible line or portion which permits it to split, rupture, or fracture upon balloon inflation. In order to facilitate withdrawal, the split sections could be adhered to the balloon surface so that they close with deflation of the balloon. In other instances, it may be desirable to cover the entire balloon with an elastic or inelastic sleeve, and in all cases, the sleeve will add to the column strength and torsional stiffness of the distal portion of the balloon section of the catheter. Such increased strength and stiffness combined to enhance the resistance to bending and to torsional buildup. Together, increased resistance to bending and torsional buildup will increase the efficiency of delivering the axial forces from a proximal end of the catheter to the distal end to overcome the obstruction of the stent strut or other materials.
  • The ability to progressively inflate the balloon from a proximal end toward a distal end can have particular advantage, when opening a stent or otherwise treating a side branch ostium. When treating a bifurcated lesion, it is common to dilate the ostium after stent deployment by positioning a distal end of the balloon in the side branch and a proximal end of the balloon in the main vessel. The balloon is inflated to dilate the ostium and position the stent struts outwardly toward the side branch in order to cover and “scaffold” the ostium. In practice, however, this procedure often pushes struts which are located distally to the balloon back into the main vessel rather than into the side branch. By progressively inflating the balloon from proximal to distal, as illustrated in FIGS. 3A and 3B, the distally advancing inflation of the balloon will push all the struts distally into the side branch, thus decreasing the risk that struts will protrude into the main vessel when the procedure is over.
  • As illustrated in FIGS. 4A and 4B, the present invention also provides for placing a constraining sleeve over a proximal portion of the balloon. In particular, a sleeve 50 which may be elastic or inelastic as described above, covers a proximal taper of the balloon 52 of catheter 48 in order to cover the pleats of the folded balloon and inhibit the balloon from catching on the struts of a stent, particularly as the catheter is withdrawn through the stent. The sleeve 50 is preferably formed from an elastic material which can recover to close a balloon and the balloon is deflated. Thus, when the procedure is over, the proximal region of the balloon will be constrained and a smooth surface presented as the catheter is withdrawn. The proximal balloon 50 also enhances both torsional stiffness and column strength, a feature which is particularly useful when the balloon is adapted to deliver stents. In preferred embodiments, catheter 48 of FIGS. 4A and 4B will be combined with a beveled distal tip 54 and optionally a braided proximal shaft portion 56 in order to further enhance torsional stiffness and column strength. In the exemplary embodiments, the braided shaft section 56 may be attached to a proximal shaft 58 which may be a hypotube, conventional polymeric balloon catheter shaft, or the like.
  • Referring now to FIGS. 5A and 5B, a balloon catheter 70 carries a short balloon 72 having a length less than 12 mm, usually less than 8 mm, and typically in the range from 3 mm to 6 mm. The balloon catheter 70 usually carries a radiopaque marker 74 at the approximate middle or mid-line of the balloon (middle of the axial dimension of the inflated balloon). Typically, the marker 74 is carried on the shaft within the balloon and will be visible under fluoroscopy to allow the middle of the balloon, i.e. the marker, to be positioned at the ostium or stent wall before inflation. When thus positioned, a distal half of the balloon is positioned largely within the side branch vessel lumen SBL, while a proximal half of the balloon remains largely in the main branch vessel lumen MBL. As the ostium is usually larger than the side branch vessel diameter, typically by about 0.5 mm, long balloons will generally enter the side branch increasing the risk of overdilation when the user is attempting to dilate stenotic material located at the ostium (which is a very typical occurrence). Use of the short balloons of the present invention minimizes the risk of overinflation of the side branch vessel.
  • While short balloons have been proposed in the past for a variety of purposes, their use in dilating the ostium of a bifurcation was hindered by their tendency to slip from the ostium back into the larger main vessel lumen. By inflating the short balloons of the present invention so that the midsection is in the ostium and preferably located within the stent structure, the balloon will be stabilized and held in place by the stent.
  • A further advantage of the short balloon is that it does not extend far into either the main branch vessel lumen MBL or side branch vessel lumen SBL. Longer balloons which extend proximally back into the main branch will tend to straighten as they are inflated. As the proximal end of a long balloon can be anchored within the main branch vessel, such straightening will then deflect the distal end of the balloon downward, thus preferentially opening struts on one side of the ostium and potentially causing an uneven dilatation.
  • While the above is a complete description of the preferred embodiments of the invention, various alternatives, modifications, and equivalents may be used. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.
  • While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.

Claims (10)

What is claimed is:
1. A balloon catheter having improved crossing characteristics, said catheter comprising
a catheter body having a distal end, a proximal end, and an inflatable balloon near the distal end,
wherein a distal tip is asymmetrically beveled relative to a longitudinal axis of the catheter body, and
wherein the catheter body comprises a braided shaft section to torsionally reinforce the distal portion thereof, thereby improving rotation of the beveled distal tip when the catheter body is placed in vasculature.
2. A balloon catheter as in claim 1, wherein at least a portion of the balloon is covered with an expandable sleeve.
3. A balloon catheter as in claim 2, wherein the expandable sleeve covers at least a distal region of the balloon to enhance column strength of a distal region of the catheter shaft and to present a smooth forward-facing surface as the catheter is advanced through the vasculature.
4. A balloon catheter as in claim 2, wherein the expandable sleeve covers at least a proximal portion of the balloon to enhance the column strength of a proximal region of the catheter body and to present a smooth proximal-facing surface as the catheter is withdrawn through the vasculature.
5. A balloon catheter as in claim 2, wherein the sleeve is elastic to expand and contract over the balloon as the balloon is inflated and deflated.
6. A balloon catheter as in claim 2, wherein the sleeve splits as the balloon is inflated.
7. A balloon catheter as in claim 1, wherein the balloon has a length when inflated in the range from 3 mm to 6 mm and a radiopaque marker at its middle.
8. A balloon catheter as in claim 7, wherein the balloon is non-distensible and has a diameter in the range from 1 mm to 5 mm when fully inflated.
9. A balloon catheter as in claim 1, wherein the braided shaft section is attached to a proximal shaft section comprising a hypotube.
10. A balloon catheter as in claim 1, wherein the braided shaft section is attached to a proximal shaft section comprising a polymeric balloon catheter shaft.
US14/546,696 2009-06-08 2014-11-18 Side branch balloon Abandoned US20150066070A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/546,696 US20150066070A1 (en) 2009-06-08 2014-11-18 Side branch balloon

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18512409P 2009-06-08 2009-06-08
US12/795,911 US10493246B2 (en) 2009-06-08 2010-06-08 Side branch balloon
US14/546,696 US20150066070A1 (en) 2009-06-08 2014-11-18 Side branch balloon

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/795,911 Continuation US10493246B2 (en) 2009-06-08 2010-06-08 Side branch balloon

Publications (1)

Publication Number Publication Date
US20150066070A1 true US20150066070A1 (en) 2015-03-05

Family

ID=43309197

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/795,911 Expired - Fee Related US10493246B2 (en) 2009-06-08 2010-06-08 Side branch balloon
US14/546,696 Abandoned US20150066070A1 (en) 2009-06-08 2014-11-18 Side branch balloon

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/795,911 Expired - Fee Related US10493246B2 (en) 2009-06-08 2010-06-08 Side branch balloon

Country Status (5)

Country Link
US (2) US10493246B2 (en)
EP (1) EP2440278A4 (en)
JP (2) JP5580886B2 (en)
CN (1) CN102573982B (en)
WO (1) WO2010144483A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018183387A1 (en) 2016-03-25 2018-10-04 Ostial Corporation Balloon catheters and methods for use
US10493246B2 (en) 2009-06-08 2019-12-03 Trireme Medical, Inc. Side branch balloon

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016579B2 (en) * 2011-06-23 2018-07-10 W.L. Gore & Associates, Inc. Controllable inflation profile balloon cover apparatus
US9370643B2 (en) 2011-06-23 2016-06-21 W.L. Gore & Associates, Inc. High strength balloon cover
US8888692B1 (en) 2011-08-26 2014-11-18 Applied Medical Resources Corporation Trocar cannula assembly and method of manufacture
US10179227B2 (en) 2013-03-12 2019-01-15 Acclarent, Inc. Resilient tube over dilator balloon
ES2935345T3 (en) 2013-03-15 2023-03-06 Applied Med Resources Trocar Cannula Assembly with Low Profile Insertion Configuration
ES2734216T3 (en) * 2014-07-04 2019-12-04 Abiomed Europe Gmbh Case for watertight access to a glass
CN112043463B (en) * 2015-08-26 2024-03-08 爱德华兹生命科学公司 Controlled balloon deployment
CN105999523A (en) * 2016-06-27 2016-10-12 南京双威生物医学科技有限公司 Dilation catheter with folded bladders
CN108853694B (en) * 2018-09-12 2024-02-27 深圳脉动医学技术有限公司 Biological saccule dilating catheter
CN109939336A (en) * 2019-03-12 2019-06-28 杭州巴泰医疗器械有限公司 A kind of belt supporting frame balloon catheter structure for blood vessel dilatation operation
JP7234462B2 (en) * 2020-11-16 2023-03-07 株式会社カネカ balloon for balloon catheter

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116318A (en) * 1989-06-06 1992-05-26 Cordis Corporation Dilatation balloon within an elastic sleeve
US6120523A (en) * 1994-02-24 2000-09-19 Radiance Medical Systems, Inc. Focalized intraluminal balloons
US6206852B1 (en) * 1999-12-15 2001-03-27 Advanced Cardiovascular Systems, Inc. Balloon catheter having a small profile catheter
US20030212410A1 (en) * 2002-05-08 2003-11-13 Stenzel Eric B. Method and device for providing full protection to a stent
US6835189B2 (en) * 2002-10-15 2004-12-28 Scimed Life Systems, Inc. Controlled deployment balloon
US20050055077A1 (en) * 2003-09-05 2005-03-10 Doron Marco Very low profile medical device system having an adjustable balloon
US20050075711A1 (en) * 2003-10-03 2005-04-07 Neary Anthony J. Balloon catheter with selectable diameter and expandable length
US20050107821A1 (en) * 2003-11-14 2005-05-19 Shanley John F. Balloon catheter with kink resistant distal segment
EP1557193A2 (en) * 2004-01-22 2005-07-27 Nipro Corporation Balloon catheter
US20090163879A1 (en) * 2007-08-27 2009-06-25 Boston Scientific Scimed, Inc. Bulging balloon for bifurcation catheter assembly and methods
US20100010303A1 (en) * 2008-07-09 2010-01-14 Ethicon Endo-Surgery, Inc. Inflatable access device

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3884242A (en) * 1971-03-29 1975-05-20 Mpc Kurgisil Catheter assembly
JPH01145074A (en) * 1987-12-01 1989-06-07 Terumo Corp Balloon catheter
US5015231A (en) * 1989-04-21 1991-05-14 Scimed Life Systems, Inc. Multipart split sleeve balloon protector for dilatation catheter
US5324261A (en) 1991-01-04 1994-06-28 Medtronic, Inc. Drug delivery balloon catheter with line of weakness
US5454788A (en) * 1991-04-24 1995-10-03 Baxter International Inc. Exchangeable integrated-wire balloon catheter
EP0553960B1 (en) 1992-01-31 1997-08-27 Advanced Cardiovascular Systems, Inc. Protective membrane for stent-carrying ballon catheter
US5368566A (en) * 1992-04-29 1994-11-29 Cardiovascular Dynamics, Inc. Delivery and temporary stent catheter having a reinforced perfusion lumen
US6312442B1 (en) 1992-06-02 2001-11-06 General Surgical Innovations, Inc. Method for developing an anatomic space for laparoscopic hernia repair
US5961765A (en) * 1994-09-20 1999-10-05 Schneider (Europe) A. G. Method of making a catheter
JP3575044B2 (en) * 1994-02-24 2004-10-06 日本ゼオン株式会社 Balloon catheter for body cavity expansion
US5628755A (en) * 1995-02-20 1997-05-13 Schneider (Europe) A.G. Balloon catheter and stent delivery system
US5549551A (en) 1994-12-22 1996-08-27 Advanced Cardiovascular Systems, Inc. Adjustable length balloon catheter
NL9500468A (en) * 1995-03-08 1996-10-01 Cordis Europ Balloon catheter and method of making it.
WO1996040349A1 (en) 1995-06-07 1996-12-19 Advanced Cardiovascular Systems, Inc. Sheath for an adjustable length balloon
US5662608A (en) * 1995-07-26 1997-09-02 Intelliwire, Inc. Low profile balloon catheter and method
JP3432060B2 (en) 1995-09-05 2003-07-28 テルモ株式会社 Vasodilator
US5997487A (en) 1995-10-11 1999-12-07 Micro Therapeutics, Inc. Infusion wire having fixed core wire
US6302875B1 (en) * 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
AU3122197A (en) 1996-05-14 1997-12-05 Embol-X, Inc. Aortic occluder with associated filter and methods of use during cardiac surgery
US6048331A (en) * 1996-05-14 2000-04-11 Embol-X, Inc. Cardioplegia occluder
US5669932A (en) * 1996-05-29 1997-09-23 Isostent, Inc. Means for accurately positioning an expandable stent
US5868707A (en) * 1996-08-15 1999-02-09 Advanced Cardiovascular Systems, Inc. Protective sheath for catheter balloons
US5980530A (en) 1996-08-23 1999-11-09 Scimed Life Systems Inc Stent delivery system
US6692483B2 (en) 1996-11-04 2004-02-17 Advanced Stent Technologies, Inc. Catheter with attached flexible side sheath
US5843027A (en) * 1996-12-04 1998-12-01 Cardiovascular Dynamics, Inc. Balloon sheath
US6010449A (en) 1997-02-28 2000-01-04 Lumend, Inc. Intravascular catheter system for treating a vascular occlusion
US6312374B1 (en) * 1997-03-06 2001-11-06 Progenix, Llc Radioactive wire placement catheter
US5810867A (en) * 1997-04-28 1998-09-22 Medtronic, Inc. Dilatation catheter with varied stiffness
US5967988A (en) * 1998-04-08 1999-10-19 Medtronic, Inc. Catheter having echogenicity enhancement
US6168586B1 (en) * 1998-08-07 2001-01-02 Embol-X, Inc. Inflatable cannula and method of using same
US7655030B2 (en) * 2003-07-18 2010-02-02 Boston Scientific Scimed, Inc. Catheter balloon systems and methods
DE19904975A1 (en) * 1999-02-06 2000-09-14 Impella Cardiotech Ag Device for intravascular heart valve surgery
US6319244B2 (en) 1999-03-16 2001-11-20 Chase Medical, L.P. Catheter with flexible and rigid reinforcements
US6884258B2 (en) * 1999-06-04 2005-04-26 Advanced Stent Technologies, Inc. Bifurcation lesion stent delivery using multiple guidewires
US6540721B1 (en) * 1999-12-29 2003-04-01 Advanced Cardiovascular Systems, Inc. Balloon catheter with flexible radiopaque polymeric marker
US6994687B1 (en) 2000-01-19 2006-02-07 Cordis Neurovascular, Inc. Inflatable balloon catheter with purge mechanism and method
US7101391B2 (en) * 2000-09-18 2006-09-05 Inflow Dynamics Inc. Primarily niobium stent
US6796960B2 (en) * 2001-05-04 2004-09-28 Wit Ip Corporation Low thermal resistance elastic sleeves for medical device balloons
NL1018018C2 (en) * 2001-05-08 2002-11-19 Blue Medical Devices B V Balloon catheter and method for manufacturing thereof.
US20020177870A1 (en) * 2001-05-25 2002-11-28 Ivan Sepetka Single lumen balloon catheter
US6746423B1 (en) * 2001-11-01 2004-06-08 Advanced Cardiovascular Systems, Inc. Catheter having improved rapid exchange junction
US6960188B2 (en) 2001-11-30 2005-11-01 Abbott Laboratories Vascular Entities Limited Catheter having enhanced distal pushability
US6699273B2 (en) 2002-02-04 2004-03-02 Scimed Life Systems, Inc. Sleeve welding collar
US7993389B2 (en) * 2002-06-13 2011-08-09 Existent Inc. Guidewire system
US7141059B2 (en) * 2002-12-12 2006-11-28 Advanced Cardiovascular Systems, Inc. Balloon catheter having a flexible distal end
US7491213B2 (en) * 2004-01-13 2009-02-17 Boston Scientific Scimed, Inc. Catheter shaft having distal support
US7591805B2 (en) 2004-03-11 2009-09-22 Merit Medical Systems, Inc. Integral flushing device
JP4443278B2 (en) * 2004-03-26 2010-03-31 テルモ株式会社 Catheter with expansion body
US20060004323A1 (en) 2004-04-21 2006-01-05 Exploramed Nc1, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US20060064064A1 (en) 2004-09-17 2006-03-23 Jang G D Two-step/dual-diameter balloon angioplasty catheter for bifurcation and side-branch vascular anatomy
US20060224113A1 (en) * 2005-03-31 2006-10-05 Van Sloten Leonard A Esophageal balloon catheter with asymmetrical balloon
JP2006334222A (en) 2005-06-03 2006-12-14 Sekisui Chem Co Ltd Balloon catheter
ATE458458T1 (en) * 2006-03-24 2010-03-15 Cordis Corp SPLIT LOCK RELEASE SYSTEM FOR SELF-EXPANDING STENTS
US20080045896A1 (en) * 2006-08-17 2008-02-21 Abott Laboratories Catheter having intermediate position markers
US20080058764A1 (en) * 2006-08-29 2008-03-06 Majercak David C Catheter Tip Configuration for Improved Crossability and Trackability
US20090112159A1 (en) * 2007-10-31 2009-04-30 David Slattery Delivery System With Profiled Sheath Having Balloon-Oriented Position
BRPI0923901B1 (en) 2008-12-31 2019-09-17 Johnson & Johnson Vision Care , Inc. Apparatus for storing and disposing of ophthalmic lens packaging
JP5580886B2 (en) 2009-06-08 2014-08-27 トライレム メディカル, インコーポレイテッド Side branch balloon

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116318A (en) * 1989-06-06 1992-05-26 Cordis Corporation Dilatation balloon within an elastic sleeve
US6120523A (en) * 1994-02-24 2000-09-19 Radiance Medical Systems, Inc. Focalized intraluminal balloons
US6206852B1 (en) * 1999-12-15 2001-03-27 Advanced Cardiovascular Systems, Inc. Balloon catheter having a small profile catheter
US20030212410A1 (en) * 2002-05-08 2003-11-13 Stenzel Eric B. Method and device for providing full protection to a stent
US6835189B2 (en) * 2002-10-15 2004-12-28 Scimed Life Systems, Inc. Controlled deployment balloon
US20050055077A1 (en) * 2003-09-05 2005-03-10 Doron Marco Very low profile medical device system having an adjustable balloon
US20050075711A1 (en) * 2003-10-03 2005-04-07 Neary Anthony J. Balloon catheter with selectable diameter and expandable length
US20050107821A1 (en) * 2003-11-14 2005-05-19 Shanley John F. Balloon catheter with kink resistant distal segment
EP1557193A2 (en) * 2004-01-22 2005-07-27 Nipro Corporation Balloon catheter
US20090163879A1 (en) * 2007-08-27 2009-06-25 Boston Scientific Scimed, Inc. Bulging balloon for bifurcation catheter assembly and methods
US20100010303A1 (en) * 2008-07-09 2010-01-14 Ethicon Endo-Surgery, Inc. Inflatable access device

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10493246B2 (en) 2009-06-08 2019-12-03 Trireme Medical, Inc. Side branch balloon
WO2018183387A1 (en) 2016-03-25 2018-10-04 Ostial Corporation Balloon catheters and methods for use
EP3600171A4 (en) * 2016-03-25 2021-03-31 Ostial Corporation Balloon catheters and methods for use
JP7195618B2 (en) 2016-03-25 2022-12-26 オスティアル コーポレイション Balloon catheter and method of use

Also Published As

Publication number Publication date
CN102573982A (en) 2012-07-11
JP5580886B2 (en) 2014-08-27
EP2440278A1 (en) 2012-04-18
EP2440278A4 (en) 2013-11-20
WO2010144483A1 (en) 2010-12-16
CN102573982B (en) 2014-09-03
US10493246B2 (en) 2019-12-03
JP2012529304A (en) 2012-11-22
JP2014208297A (en) 2014-11-06
US20110144583A1 (en) 2011-06-16
JP6104213B2 (en) 2017-03-29

Similar Documents

Publication Publication Date Title
US10493246B2 (en) Side branch balloon
US11497901B2 (en) Systems and methods for treating a vessel using focused force
US10143824B2 (en) Catheter assemblies and methods for stabilizing a catheter assembly within a subintimal space
US6379365B1 (en) Stent delivery catheter system having grooved shaft
US7131981B2 (en) Device and method for converting a balloon catheter into a cutting balloon catheter
US6190393B1 (en) Direct stent delivery catheter system
US8088102B2 (en) Dilation and stent delivery system for bifurcation lesions
US6544218B1 (en) Catheter with biased shaft
US20130261545A1 (en) Drug eluting folding balloon
US20050049677A1 (en) Baloon catherter with non-deployable stent
US20070244431A1 (en) Balloon catheter having a textured member for enhancing balloon for stent retention
US10251766B2 (en) Balloon catheters and systems and methods for delivering stents using such catheters
WO2002094336A2 (en) Short sleeve stent delivery catheter and methods
US20020055733A1 (en) Catheter assembly and method of use
US9364642B2 (en) Balloon catheter systems and methods for bypassing an occlusion in a blood vessel
US6712807B2 (en) Catheter having improved flexibility control
US20160175569A1 (en) Device for treating vascular occlusion
JP2004073870A (en) Over-the-wire catheter with slider to grip guide wire
US6932836B2 (en) Catheter and stent delivery system
US20210100670A1 (en) BEVELED CORONARY STENT AND CATHETER FOR USE IN A BRANCH WITH LESS THAN 90º ANGLE AND ASSOCIATED METHODS

Legal Events

Date Code Title Description
AS Assignment

Owner name: TRIREME MEDICAL, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MATOV, NADIA P.;DE LOS SANTOS, JAYSON;PIVA, GUILLERMO;AND OTHERS;SIGNING DATES FROM 20100714 TO 20100722;REEL/FRAME:035849/0890

AS Assignment

Owner name: TRIREME MEDICAL, LLC, CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:TRIREME MEDICAL, INC.;REEL/FRAME:036777/0172

Effective date: 20130711

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: TELEFLEX LIFE SCIENCES UNLIMITED COMPANY, BERMUDA

Free format text: LICENSE;ASSIGNORS:QT VASCULAR LTD.;TRIREME MEDICAL, LLC;QUATTRO VASCULAR PTE. LTD.;AND OTHERS;REEL/FRAME:046196/0282

Effective date: 20180621